Colpotrophine (Postmenopausal Vaginal Atrophy)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Related Reports 8
3 Disease Overview 9
3.1 Etiology and Pathophysiology 9
3.1.1 Etiology 9
3.1.2 Pathophysiology 9
3.1.3 Prognosis 10
3.1.4 Quality of Life 10
3.2 Symptoms 10
4 Disease Management 12
4.1 Treatment Overview 12
4.2 Treatment Guidelines 12
4.3 Disease Management 13
5 Competitive Assessment 16
5.1 Overview 16
5.2 Strategic Competitor Assessment 17
6 Colpotrophine (promestriene vaginal cream/ovule) 19
6.1 Overview 19
6.2 Efficacy 20
6.3 Safety 20
6.4 SWOT Analysis 21
6.5 Forecast 21
7 Appendix 22
7.1 Bibliography 22
7.2 Abbreviations 24
7.3 Methodology 25
7.4 Forecasting Methodology 25
7.4.1 Diagnosed postmenopausal atrophy patients 26
7.4.2 Percent Drug-Treated Patients 26
7.4.3 General Pricing Assumptions 26
7.4.4 Individual Drug Assumptions 27
7.4.5 Generic Erosion 27
7.5 Physicians and Specialists Included in This Study 28
7.6 About the Authors 29
7.6.1 Author 29
7.6.2 Epidemiologists 29
7.6.3 Global Director of Epidemiology and Clinical Trials Analysis 30
7.6.4 Director of Oncology, Hematology and Gender Health 30
7.6.5 Global Head of Healthcare 31
7.7 About GlobalData 32
7.8 Disclaimer 32